The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Spiriva Respimat contains the active ingredient tiotropium. Spiriva ...
RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, ...
Spiriva (tiotropium), available as Respimat and Handihaler, is prescribed to treat COPD and asthma but should not be used as a rescue inhaler for sudden breathing issues. Common side effects of ...
Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) is now available for the long-term maintenance treatment of asthma in patients ages ≥12 years. Boehringer Ingelheim announced ...
-- Adding SPIRIVA RESPIMAT improved lung function and asthma symptom control in children and adolescents, regardless of their type of allergic asthma, compared to placebo "Many people with asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results